Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: A phase II study

Nithya Ramnath, Jihnhee Yu, Nikhil I. Khushalani, Ronald H. Gottlieb, James K. Schwarz, Renuka V. Iyer, Youcef M. Rustum, Patrick J. Creaven

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: A phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences